Quick Answer
Crinetics Pharmaceuticals, Inc. reported Shares Outstanding of 95.58 million shares for fiscal year 2025.
Crinetics Pharmaceuticals, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 95.58M | +2.9% |
| 2024 | 92.93M | +36.3% |
| 2023 | 68.17M | +110.8% |
| 2023 | 32.34M | -40.0% |
| 2022 | 53.88M | +13.2% |
| 2021 | 47.60M | +44.2% |
| 2020 | 33.00M | +36.0% |
| 2019 | 24.26M | +100739.5% |
| 2018 | 24,061 | -98.4% |
| 2017 | 1.55M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 94.55M | +17.0% | +0.4% |
| June 30, 2025 | 94.13M | +18.7% | +0.6% |
| March 31, 2025 | 93.53M | +19.1% | +0.6% |
| December 31, 2024 | 92.93M | +36.3% | +14.9% |
| September 30, 2024 | 80.84M | +21.2% | +1.9% |
| June 30, 2024 | 79.32M | +45.1% | +1.0% |
| March 31, 2024 | 78.54M | +45.5% | +15.2% |
| December 31, 2023 | 68.17M | — | +2.2% |
- Crinetics Pharmaceuticals, Inc. showed an increase of +2.9% in Shares Outstanding compared to the prior fiscal year.
- Over the 2017–2025 period, Crinetics Pharmaceuticals, Inc.’s shares outstanding has grown by 6067.8% (from 1.55 million shares to 95.58 million shares).
- The most recent figure is from Crinetics Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: